Insider trading

Period: 120 months Stock: NVCR + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

519 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

519 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

519 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

519 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
519 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
519 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

519 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
30 Jul 2021
Benaim Ely Chief Medical Officer
Sold, plan not stated
$103.48K 651 at 158.96
2.2%
6 Jul 2021
LEUNG GABRIEL Director
Sold, plan not stated
$183.54K 1,000 at 183.54
1.4%
10 Jun 2021
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$5.06M 23,540 at 215.00
23.2%
7 Jun 2021
LEUNG GABRIEL Director
Sold, plan not stated
$204.55K 1,000 at 204.55
1.4%
27 May 2021
Benaim Ely Chief Medical Officer
Sold, plan not stated
$366.60K 1,833 at 200.00
5.9%
12 May 2021
Benaim Ely Chief Medical Officer
Sold, plan not stated
$350.67K 1,943 at 180.48
6.3%
11 May 2021
Benaim Ely Chief Medical Officer
Sold, plan not stated
$407.43K 2,262 at 180.12
6.8%
10 May 2021
Weinberg Uri Chief Science Officer
Sold, plan not stated 2×
$1.07M 5,650 at 189.65
15.1%
10 May 2021
Benaim Ely Chief Medical Officer
Sold, plan not stated
$347.63K 1,833 at 189.65
5.2%
5 May 2021
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$257.57K 1,290 at 199.67
1.3%
5 May 2021
LEUNG GABRIEL Director
Sold, plan not stated
$199.67K 1,000 at 199.67
1.4%
4 May 2021
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$209.49K 1,043 at 200.86
1.0%
13 Apr 2021
Danziger Asaf Chief Executive Officer
Sold, plan not stated
$19.24M 97,973 at 196.34
92.3%
Sold half or more
13 Apr 2021
DOYLE WILLIAM F Executive Chairman
Sold, plan not stated 22×
$18.96M 95,000 at 199.55
14.6%
13 Apr 2021
LEUNG GABRIEL Director
Sold, plan not stated 2×
$1.19M 6,000 at 198.84
7.7%
13 Apr 2021
Benaim Ely Chief Medical Officer
Sold, plan not stated 3×
$1.19M 5,958 at 200.00
15.2%
1 Apr 2021
DOYLE WILLIAM F Executive Chairman
Sold, plan not stated
$1.06M 7,928 at 134.12
1.2%
23 Mar 2021
Weinberg Uri Chief Science Officer
Sold, plan not stated
$544.88K 3,892 at 140.00
9.7%
9 Mar 2021
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$461.96K 3,524 at 131.09
3.4%
8 Mar 2021
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated
$392.94K 3,004 at 130.81
1.9%
8 Mar 2021
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$343.63K 2,627 at 130.81
2.4%
8 Mar 2021
Longsworth Todd Christopher General Counsel
Sold, plan not stated
$314.46K 2,404 at 130.81
3.4%
8 Mar 2021
Leonard Frank X Chief Development Officer
Sold, plan not stated
$100.07K 765 at 130.81
0.8%
8 Mar 2021
Cordova Ashley Chief Financial Officer
Sold, plan not stated
$100.07K 765 at 130.81
2.1%
5 Mar 2021
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$598.46K 4,550 at 131.53
4.1%
5 Mar 2021
Benaim Ely Chief Medical Officer
Sold, plan not stated
$383.80K 2,918 at 131.53
8.1%
4 Mar 2021
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated
$530.13K 3,854 at 137.55
2.4%
4 Mar 2021
Longsworth Todd Christopher General Counsel
Sold, plan not stated
$424.22K 3,084 at 137.55
4.2%
4 Mar 2021
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$365.62K 2,658 at 137.55
2.6%
4 Mar 2021
Benaim Ely Chief Medical Officer
Sold, plan not stated
$259.70K 1,888 at 137.55
5.0%
4 Mar 2021
Cordova Ashley Chief Financial Officer
Sold, plan not stated
$77.99K 567 at 137.55
1.5%
4 Mar 2021
Leonard Frank X Chief Development Officer
Sold, plan not stated
$77.99K 567 at 137.55
0.6%
3 Mar 2021
Benaim Ely Chief Medical Officer
Sold, plan not stated
$523.96K 3,475 at 150.78
8.4%
3 Mar 2021
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$327.80K 2,174 at 150.78
2.1%
2 Mar 2021
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated
$363.71K 2,392 at 152.05
1.6%
2 Mar 2021
Longsworth Todd Christopher General Counsel
Sold, plan not stated
$358.08K 2,355 at 152.05
3.6%
2 Mar 2021
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$138.67K 912 at 152.05
1.0%
2 Mar 2021
Leonard Frank X Chief Development Officer
Sold, plan not stated
$65.38K 430 at 152.05
0.5%
2 Mar 2021
Cordova Ashley Chief Financial Officer
Sold, plan not stated
$65.08K 428 at 152.05
1.5%
22 Feb 2021
Weinberg Uri Chief Science Officer
Sold, plan not stated
$1.14M 6,500 at 175.50
19.1%
15 Jan 2021
Longsworth Todd Christopher General Counsel
Sold, plan not stated 24×
$11.01M 63,814 at 172.48
51.7%
Sold half or more
21 Dec 2020
Benaim Ely Chief Medical Officer
Sold, plan not stated 2×
$389.27K 2,484 at 156.71
7.8%
18 Dec 2020
Danziger Asaf Chief Executive Officer
Sold, plan not stated 23×
$32.72M 207,910 at 157.39
51.3%
Sold half or more
18 Dec 2020
HILLEMAN JERYL L Director
Sold, plan not stated
$416.00K 2,500 at 166.40
42.4%
2 Nov 2020
Cordova Ashley Chief Financial Officer
Sold, plan not stated
$27.00K 230 at 117.41
0.9%
25 Sep 2020
Weinberg Uri Chief Science Officer
Sold, plan not stated 2×
$1.58M 15,250 at 103.35
35.6%
18 Sep 2020
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated 5×
$902.29K 8,262 at 109.21
5.5%
17 Sep 2020
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated 6×
$1.36M 12,500 at 108.60
8.1%
16 Sep 2020
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated 14×
$2.36M 22,012 at 107.35
13.4%
15 Sep 2020
Danziger Asaf Chief Executive Officer
Sold, plan not stated
$10.20M 103,000 at 99.00
34.3%
Showing 151–200 of 519. ← Newer Page 4 of 11 Older →